Nonhuman Primate Models of Alzheimer-Like Cerebral Proteopathy

Author(s): Eric Heuer, Rebecca F. Rosen, Amarallys Cintron, Lary C. Walker

Journal Name: Current Pharmaceutical Design

Volume 18 , Issue 8 , 2012

Become EABM
Become Reviewer


Nonhuman primates are useful for the study of age-associated changes in the brain and behavior in a model that is biologically proximal to humans. The Aβ and tau proteins, two key players in the pathogenesis of Alzheimers disease (AD), are highly homologous among primates. With age, all nonhuman primates analyzed to date develop senile (Aβ) plaques and cerebral β-amyloid angiopathy. In contrast, significant tauopathy is unusual in simians, and only humans manifest the profound tauopathy, neuronal degeneration and cogni-tive impairment that characterize Alzheimers disease. Primates thus are somewhat paradoxical models of AD-like pathology; on the one hand, they are excellent models of normal aging and naturally occurring Aβ lesions, and they can be useful for testing diagnostic and therapeutic agents targeting aggregated forms of Aβ. On the other hand, the resistance of monkeys and apes to tauopathy and AD-related neurodegeneration, in the presence of substantial cerebral Aβ ; deposition, suggests that a comparative analysis of human and nonhuman primates could yield informative clues to the uniquely human predisposition to Alzhei s disease.

Keywords: Aging, Alzheimer's disease, amyloid, cerebral amyloid angiopathy, monkeys, neurodegeneration, senile plaques, tauopathy, Nonhuman primates, Aβ lesions

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2012
Page: [1159 - 1169]
Pages: 11
DOI: 10.2174/138161212799315885
Price: $65

Article Metrics

PDF: 39